Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

about

Exploring Neural Substrates Underlying the Execution of Behavior Across the Whole Brain.

P2860

Q41654985-FB942504-0FB9-4BF5-B7A3-C503C9B41F46

P2860

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

Item

http://www.wikidata.org/entity/Q38616824

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

@en

type

Item

label

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

@en

prefLabel

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

@en

P1476

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

@en

P2093

Oksana Suchowersky

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

The growing spectrum of antibody-associated inflammatory brain diseases in children.

Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Diagnosis and the premotor phase of Parkinson disease.

Apathy in Parkinson's disease: A systematic review and meta-analysis.

Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease.

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Parkinson's disease: From human genetics to clinical trials.

P2888

nrneurol.2015.201

P304

618-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2015.201

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030841665

http://www.w3.org/2001/XMLSchema#string

P698

26503930

http://www.w3.org/2001/XMLSchema#string

P921

pathogenesis

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

about

P2860

P2860

Decade in review-movement disorders: tracking the pathogenesis of movement disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P921